Umoja and TreeFrog team up to overcome challenges facing ex vivo allogeneic therapies
Umoja Biopharma and TreeFrog Therapeutics have formed an alliance to address challenges facing ex vivo allogeneic therapies in immuno-oncology, including issues scaling up production to reach all patients.